Aspirin-exacerbated Respiratory Disease Clinical Trial
Official title:
Effects of a High or Low Salycilate Diet on Urinary Leucotriene E4 Levels and Clinical Features in Patients With Aspirin Exacerbated Respiratory Disease
On day one, two groups of nine patients each will respectively recieve the tree daily meals (breakfast, Lunch and dinner) in a controled clinical setting. Group 1 will recieve a low-salycilate diet, and group 2 a high-salycilate diet. Two hours after each meal, urinary Leucotriene E4, FEV1, FVC, FEV1/FVC and total nasal resistance will be measured. On day 7, after clearance time, group 1 will recieve high-salycilate diet and group 2 low salycilate diet and the same measurements will be obtained.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03595488 -
Dupilumab for Aspirin-exacerbated Respiratory Disease
|
Phase 2 | |
| Enrolling by invitation |
NCT03627481 -
Sleep Quality After Nasosinusal Surgery in AERD Patients
|
N/A | |
| Recruiting |
NCT05672030 -
Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
|
||
| Completed |
NCT03849625 -
Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand
|
||
| Recruiting |
NCT05031455 -
Mechanisms of Dupilumab in AERD
|
Phase 2 | |
| Recruiting |
NCT04147013 -
Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients With CRS
|
Phase 4 | |
| Completed |
NCT01631773 -
A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only
|
N/A | |
| Recruiting |
NCT05575037 -
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
|
Phase 2 | |
| Completed |
NCT03326063 -
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban
|
Phase 2 |